Document is current
Any future updates will be listed below
-
Authors
Pujol-Calderón, Fani https://orcid.org/0000-0001-7920-2884
Zetterberg, Henrik
Portelius, Erik
Löwhagen Hendén, Pia
Rentzos, Alexandros
Karlsson, Jan-Erik
Höglund, Kina
Blennow, Kaj
Rosengren, Lars E.
-
Funding
Funding for this research was provided by:
Swedish state (ALFGBG-829081, ALFGBG-720931)
Stiftelsen Edit Jakobssons Donationsfond
Vetenskapsrådet (2017-00915, 2018-02532)
Sewdish Alzheimer Foundation (AF-742881)
Hjärnfonden (FO2017-0243)
Sewdish state (ALFGBG-715986)
Knut och Alice Wallenbergs Stiftelse
European Research Council (681712)
Stiftelsen Systrarna Greta Johanssons och Brita Anderssons Minnesfond
- License Information
-
More Information
Article History
Received: 2 June 2020
Revised: 23 February 2021
Accepted: 28 February 2021
First Online: 15 March 2021
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval for the study was obtained from Gothenburg Regional Ethical Review Board (Dnr 013-13). Patients gave their informed consent before being sorted in the study.
: Not applicable
: HZ has served at scientific advisory boards for the Roche Diagnostics, Wave, Samumed and CogRx and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg (all outside submitted work).KB holds the Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences.
